Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 251.8× sales vs its 103.2× historical median P/S.
Fair value ≈ $23.36 · price $56.99 today
Overvalued · 144% above
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
@cubie @jenbunn @simon58 @EBE_Day @ribbey @SamwiseTheBrave @TraderRapp @tonyctl @lukenight @twincam
$lly acquired this company $morf last year and their ulcerative colitis drug data was supposed to come first half of this year. i don’t see any news on it. maybe strangle $lly since it’s the last day of the quarter.
@Digital_Waffle_Pirate I think he'll be fine. Likely he'll be a board member of the reverse merger combined company. He was a director of $MORF and that got bought out so he made a ton there. Him being a director of companies is a better role for him than running $KRON
$RNAC Nice to see what happened to $MORF and $SRRK, keeps the dream alive that Springer will see us go above $43 where my BEP is. It's been a long road and winding road since 2021.....
$MORF stockholder filed a claim against Morphic Holding to block its merger with Lilly until issues are resolved or to seek damages if it goes through.
You can join this case to be notified about potential recovery: https://11thestate.com/cases/morphic-investor-suit
$MORF stockholder filed a claim against Morphic Holding to block its merger with Lilly until issues are fixed or, if it proceeds, to seek damages for losses.
You can join this case to be notified about potential recovery:
https://11thestate.com/cases/morphic-investor-suit
Morphic Holding $MORF tender offer from $LLY expires tonight
- Eli Lilly (LLY) tender offer to acquire MORF at $57.00/cash per share
- Tender offer expires at midnight tonight, August 15th
- Shares of MORF to be delisted after 8PM
More information :
https://www.sec.gov/Archives/edgar/data/1679363/000119312524194060/d877088dsc14d9a.htm
$MORF stockholder filed a claim against Morphic Holding to block its merger with Lilly until issues are fixed or, if it proceeds, to seek damages for losses.
You can join this case to be notified about potential recovery: https://11thestate.com/cases/morphic-investor-suit
$MORF https://www.intratio.com/stock-forecast/MORF Our automated equity analyst estimates the price action of this stock plainly has a bad short-term setup and is anticipated to lose heights in the next 90 days
